Extended-Infusion TZP Tied To Lower Risk Of CDI, Mortality Over Standard-Infusion TZP, Study Finds

Infectious Disease Advisor (4/3, Nye) reports, “Extended-infusion piperacillin-tazobactam (TZP) is associated with decreased rates of incident Clostridioides difficile infection and mortality compared with standard-infusion TZP, according to findings of a...